Basilea Pharmaceutica AG (BPMUF)
Basilea Pharmaceutica Market Cap: 776.06M for Dec. 31, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| BeOne Medicines Ltd. | 33.62B |
| AC Immune SA | 315.88M |
| CRISPR Therapeutics AG | 4.998B |
| Addex Therapeutics Ltd. | 9.511M |
| NewCelX Ltd. | 0.8565M |
Market Cap Related Metrics
| PS Ratio | 3.219 |
| PEG Ratio | 0.3162 |
| Price to Free Cash Flow | 9.746 |
| Price | 63.25 |
| Earnings Yield | 9.73% |
| PEGY Ratio | 0.3162 |
| Operating PE Ratio | 10.03 |
| Normalized PE Ratio | 10.28 |